Dr. Said Ismail
A/President & Chief Scientific and Operations Officer
Qatar Precision Health Institute (QPHI)
Dr. Said Ismail holds a Ph.D. from the University of Oxford and an MSc from University College London (UCL). His experience extends over 25 years and involves research, education, clinical diagnostics, consultancy and management, including work at the Ludwig Institute for Cancer Research at UCL/UK, advisory roles at regional and international pharma/biotech companies, and a professor and director at the University of Jordan Medical School and the Clinical Genetic Diagnostics Laboratory at the University Hospital.
In 2015, Dr. Ismail Joined Qatar Foundation to help in its efforts to launch the Qatar Genome Project and helped build a team and see the project grow into one of the largest population genomics initiatives in the region shedding light on the genetic makeup of Qataris as well as over 400 million genomically underrepresented Arabs.
Said also holds the position of an adjunct professor at both the Hamad Ben Khalifa University and Qatar University and is a board member at the Shoman Research Fund as well as the Transplant Immunology Research Centre of Excellence (TIREX) at Koç University, Istanbul/Turkey. He is also the first president and co-founder of the International Society on Aptamer Nanotechnology and an editorial board member in multiple international journals.
Dr. Ismail won several awards including the Said Foundation prize for young Arab researchers in the UK in 2001, the Ali Mango Award for distinguished Jordanian researchers in 2012 and the Shoman award for Arab researchers in biomedical sciences in 2013.
Dr. Ismail has special interest in promoting research among young Arab students. He launched one of the largest efforts to enhance the Arabic medical and scientific content on the internet; The “Bel-Arabi” initiative and he is also a Board member of the Phi Science Institute, which aims to encourage research among Arab youth.
